Challenge to research by Spurgeon, D.
Current contraceptive technology cannot be regarded as 
adequate to meet either individual or 5ocietal needs in either 
industrial or developing nations, and iunding mat be con- 
tinued ata much higher level in order to improve it. 
That is the conclusion of a study involving more than 160 
expert5 in 26 nations that was initiated by the Ford Founda- 
tion, with the collaboration of the Rockefeller Foundation 
and the IDRC. The study has resulted in a report, Reproduction 
and Human Welfare: A Challenge to Research, (Roy 0. 
Creep, Marjorie A. Koblinsky. and Frederick S. Jaffe, pub- 
lished by the MIT Press). 
A decline in funding for contraceptive research led to the 
study: in the face of growing worldwide population prob- 
lems, funding dropped after reaching a peak in 1374 of $119 
million, to less than $109 million in 1976. The report 
concludes that at least three times the 1974 level (or about 
$361 million) is needed to pursue research leads for new, 
effective, reversible, safe and inexpensive fertility control 
methods. 
Those responsible for the study do not expect to find an 
ideal, all-purpose contraceptive suitable for every individual. 
The diversity of personal, cultural, religious and economic 
circumstances is too great - and in fact the needs of the 
individual vary at different stages of life. 
“What is needed,” say5 the book, “is a broad array of 
contraceptive methods that require less complex distribution 
systems, that are safer, less discomforting, and more conve- 
nient than current methods, that combine high acceptability 
with high continuity of use, and that are suited to the diverse 
requirements of the world.” 
In discussing the book (which he says gathers and orders 
“what we know and do not know about the reproductive 
process”), McCeorge Bundy, president of the Ford Founda- 
tion, told a press conference that while “some of us may have 
become rather inured to cries of alarm about the ‘population 
explosion’. the fact remains that the growth of human 
population in the developing world continues at unpre- 
cedented levels. 
“While fertility has begun to fall in six of tie eight largest 
developing countries, so has mortality, and the next quarter 
century is expected to witness a continuation of the very high 
rate of population growth - about 2.3 percent per annum - 
experienced in the last 25 years.” 
Whether population grows exponentially in the 215t Cen- 
jury, or whether as projected by the United Nations, the rate 
of growth start5 decreasing, to stabilize sometime after 2075, 
the consequences for human welfare are deeply disturbing. 
McBundy said. Illiteracy will increase as the number of 
children surpasses the expansion of school facilities, un- 
employment will increase, income will be even more un- 
evenly distributed, and the population will be fed only if large 




UKited St&es has ceased to be a prbbiem that diarms us at the 
moment, the epidemic of unplanned, illegitimate adolescent 
14 
pregnancies is a grave domestic problem.” Fifty-four percent 
of all births to teenagers in the United States in 1974 were 
conceived out of wedlock and about two-third5 of these 
babies were born out oi wedlock. In addition, one third of 
abortions performed in the United States are on teenagers. 
Currently used contraceptive method5 are in general quite 
safe - and certainly, for women up to the age of 40, safer 
than the risks associated with pregnancy. For example, Dr. 
Kenneth I. Ryan. chairman of Harvard Medical School’5 
department of obstetrics and gynaecology, said: “The mater- 
nal mortality rate for pregnancy is 20 per 100,000 in de- 
veloped nations and averages 40 per 100,000 where medical 
care is less advanced. The mortality rate for the pill “5% is 3 
per 100,000. .” 
The contraceptive pill is also the most effective method of 
birth control. In fact, Dr. Ryan said. there is an inverse 
relationship between success of a contraceptive method in 
preventing pregnancy and the safety of the method used. But 
the lower safety of the most effective methods is compen- 
sated for bv removal of the risk inherent in the extra pregnan- 
cie5 they p;event. 
Thus the risk ofdeath for women taking the pill is five-fold 
lower than that for women who use no-contraceptives and 
risk pregnancy instead. The so-called “safer” methods, such 
as the diaphragm or the condom, may on balance be more 
dangerous than oral contraceptives to the extent that they are 
less effective in preventing pregnancy. 
Despite this, current methods of contraception still have 
many drawbacks. Pill user5 do risk side effects, ranging from 
benign lwer turnours, myocardial infarction (heart attack), 
and ectopic pregnancy (one that occur5 outside the womb), 
to gall bladder disease. The side effect5 may even include 
malignancies of the uteru5 and the breast, though to date this 
has not been proved. “Since it is well known that the 
development of a malignancy may take many years, this issue 
cannot be regarded as settled,” said Dr. Elizabeth B. Connell, 
associate director for health sciences at the Rockefeller 
Foundation. 
Dr. Connell went on to list side effect5 of the intra-uterine 
devices (IUDS). including: perforation of the uteru5 at time of 
insertion, development-of pain and bleeding necessitating 
removal, and increased risk of spontaneous abortion with the 
Dalkon shield (a variety of IUD) when it was left in place after 
pregnancy occurred. Infections were increased almost 
seven-fold with almost all IULX, sometime5 making future 
childbearing impossible. Dr. Connell said, suggesting to 
some that women who had never had children should not 
perhaps use them. And as with the pill, there is increased risk 
of ectopic pregnancy. 
All these risks, reported in the press, have led in recent 
months to an increasing number of women returning to safer 
but lesseffective methodsof contraception, Dr. Connell said. 
The authors of Reproduction and Human Welfare and the 
experts assembled at the Ford Foundation new5 briefing 
discussed a number of promising a~cenues of research to 
develop alternatives to current contraceptives. These in- 
cluded an anti-pregnancy vaccine (see page 12); a pill for 
Birth‘ control method; of the future may include a nasal * 
‘spray now undergoing trials in four countries. The spray 
works by depressing the centre in the brain that releases 
hormones necessary for pregn‘ancy, says its developer, Dr. 
” 
T.C. Anand Kumar, of the Department of Anatomy of the 
All-India Institute of Medical Science. 
His experiments were described wiih several others on the 
frontier of birth control research at a recent seminar or- 
ganized by the Zoology Department oi Delhi University. 
. The active ingredient of Dr. Kumar’s spray is a minute dose 
of progesterone, the female hormone used in birth control 
” pills. The two-microgram dose is sprayed up the nostril sixto 
* 10 days aiter the mensfrual cycle begins. No side efiects were 
iound in extenswe experiments on monkeys, Dr. Kumar said. 
,_ k-115 Institufe recommended the spray to an intematvxai 
- organization which is now testing it at IWO centres in India, 
three in Korea, in Mexico and in London, England. Dr. Kumar 
says the spray needs at least.two yeas more testing in 
males to suppress sperm formation; drugs that keep the : : experimental tIeid tr,ais. 
iettilized owm from Implanting in ihe womb; longer-acting Dr. M. R. Prasad, of Delhi University’s Zoology Depart- 
contraceptive agents that can be given by injectlon, im- ment, gave (a German-produced drug called cypiorerone 
planted under the skin or absorbed through an inter-vaginal ’ ., 
acetate to male lab animals. He found sperm cells did not 
ring; and a substance that, when admtnistered to a young mawre as a result. Sperm production was not reduced, but 
male, would allow him to develop normally sexually but normal animal mating resulted in no pregnancies. The World 
would block sperm production until he was ready to become Health Organization JWHO) took up Dr. Prasad’s animal 
1 i,,hnr results and i arranged for clinical tests in Germany and at 
mai Institute of Health and Family Planning 
Ci,rl,llCI. 
The male pill of the future probably will contain the male 
/ I India’s Natk 
sex hormone, testosterone. It will have to be taken with 
(NIHFP). 
absolute regularity, because sperm reproduction would begin Dr. N.R. Moudgal, a biochemistry professor ar Bangalore’s 
immediately the user stopped taking it. Tests already have Indian lnsrituie of Science, used an injected animal antibody 
been carried out with such a pdi. to neutrahre the hormone released from the fertilized egg 
The proposed contraceptive for the young sexually active that keeps the f&us-to-be attached to the wall of the “terus. 
male who is not ready to become a father is so far just With this hormone neutraiued, monkeys which were 
hypothetical, but it is theoretically feasible. The proposal injected in the first month oi their missed period, lhad normal 
follows on the very recent discovery oi a substance that may 
: 
mewtruation three days after injection. The process now 
be a hormone, produced by the Sertoli cells in the i&es. The awaits clearance from the -All-India Institute of Medical 
substance has been named inhibin because it inhibits another : 
Science, for human.experimentation to neutralize the human 
hormone, w, believed to be necessary ior formation of: 
hormone, chorlonicgonadotrophiti. 
spermatozoa. If fhis substance could be administered orally Another All-India researcher, Dr. K.R. Laumas, has had 
or otherwise, it could prevent sperm formation until father- 100 percent success with reversing sterilization in rats. In 
hood was desired. vasectomy the speim-carrying tubes are cut, making the 
Current female oral contraceptives use a high dose of sterilization permanent. Instead, Dr. Laumas inserts a thread- 
estrogen to block ovulation - and it is this that causes the ” like copper-alloy wire into the tube. This blocks sperm and 
side effects. Another way to prevwr pregnancy would he lo sterilizes the rat. To revewe sferilizaion, the wire is simply 
block the action of the hormone progesterone, which is removed in another operation. Dr. Laumas is continuing the 
absolutely necessary to prepare the uterus for the implanta- experiments in monkeys. 
tion of the fertilized egg. This method would avoid overdos- .india’s Central Drug Research Institute has developed a 
ing the woman wirh a hormone and thus upsetting her new drug called centchroman, believed to have potential as a 
metabolism. A contraceptive that would block the action of post-coital (“morning after”) contraceptive. It has worked on 
’ progesterone (which is required ior little else than conception several kinds oi laboratory animals, and imay now be tried on 
and maintenance of pregnancy) is believed to be possible humans, the seminar was told. 
+e~ adequate funds. Meanwhile, a recent repon from the N~FP cautions, “Al- 
Four long-acting injectable contraceptives for women are though some effective methods for contraception are availa- , 
already being used in various countries (they are effective hle, none can be said to be free from some drawbacks, either 
from one to three months). They are well received because in the form of side effects and/or in lacking ease and 
women in developing countries land some in the United ’ : simplicity of use. A large number of people are taking 
States) believe injectable drugs are more effective and they .. chemical and biological preparations as a result of modern 
are wed TO receiving them. The drugs are also easily adminis- medical public health and family planning practices. There 
tered by relatively untrained personnel. Research is necessary are wide gaps in our knowledge in these fields, particularly in 
to remove the major side effect - abnormal bleeding and 
that pertaining to the human being.” 
cessatim of menstruation. Clinical trials have also been The repon points out that birth control is evolving into 
undertaken on steroids inserted under the skin, which could family planning, and will become family welfare planning, 
he effective from six months to six years. And a vaginal ring 
has been tested that coniaitx a contraceptive steroid that is 
: ,_ making the scientific objective much wider than mere family ,imitation, 
absorbed through the vagina. The ring is fitted by the wearer The objective is now extended, the report says, io include 
and can be used for six months. total iamily welfare, including spacing and limitation of 
To develop such methods - and possibly others - the children, treatment of the infertile, mother and child care, 
authors of Reproduction and Human Welfare say about $500 I .” and ultimately an imprcwement in the quality of the popula- 
mlllion will be needed by 1980. And the bulk of the funds tion. 
will have to come from governmental agencies, principally in This report was 6riginaliy prepared and distributed by ihe 
the United States, Europe, Canada, Israel, Australia and Science Service oiowinnews, a specialized new service on 
Japan, and the international assistance agencies. 
* 
n science in developmenf supported jointly by the Press ‘Foun- 
d&ion of Asia and the IDRC. For more information on 
Science writer David Spurgeon is director of the I&‘S m~itinews Science S&ice, write P.O.’ Box 1843, Manfia, 
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